Joel Greenblatt's AMED Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 0 shares of Amedisys, Inc. (AMED) worth $0, representing 0.00% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 40 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in AMED, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2015, adding 355,859 shares. Largest reduction occurred in Q3 2025, reducing 342,392 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Amedisys (AMED) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amedisys (AMED) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2014 | +23,349 | New Buy | 23,349 | $29.34 |
| Q1 2015 | +16,185 | Add 69.32% | 39,534 | $26.79 |
| Q2 2015 | +355,859 | Add 900.13% | 395,393 | $39.73 |
| Q3 2015 | -258,006 | Reduce 65.25% | 137,387 | $37.97 |
| Q4 2015 | +208,525 | Add 151.78% | 345,912 | $39.32 |
| Q1 2016 | -116,209 | Reduce 33.59% | 229,703 | $48.34 |
| Q2 2016 | -178,138 | Reduce 77.55% | 51,565 | $50.48 |
| Q3 2016 | -45,627 | Reduce 88.48% | 5,938 | $47.49 |
| Q4 2016 | -5,938 | Sold Out | 0 | $0.00 |
| Q3 2017 | +7,248 | New Buy | 7,248 | $56.02 |
| Q4 2017 | +101,470 | Add 1399.97% | 108,718 | $52.71 |
| Q1 2018 | -108,718 | Sold Out | 0 | $0.00 |
| Q4 2018 | +6,505 | New Buy | 6,505 | $117.14 |
| Q1 2019 | +3,188 | Add 49.01% | 9,693 | $123.28 |
| Q2 2019 | +6,250 | Add 64.48% | 15,943 | $121.43 |
| Q3 2019 | -9,863 | Reduce 61.86% | 6,080 | $131.09 |
| Q4 2019 | -2,458 | Reduce 40.43% | 3,622 | $167.03 |
| Q2 2020 | -55 | Reduce 1.52% | 3,567 | $198.49 |
| Q1 2021 | +204 | Add 5.72% | 3,771 | $264.92 |
| Q2 2021 | +6,279 | Add 166.51% | 10,050 | $244.98 |
| Q3 2021 | +737 | Add 7.33% | 10,787 | $149.07 |
| Q4 2021 | +381 | Add 3.53% | 11,168 | $161.89 |
| Q1 2022 | +4,516 | Add 40.44% | 15,684 | $172.28 |
| Q2 2022 | +1,604 | Add 10.23% | 17,288 | $105.10 |
| Q3 2022 | +6,035 | Add 34.91% | 23,323 | $96.77 |
| Q4 2022 | -2,297 | Reduce 9.85% | 21,026 | $83.54 |
| Q1 2023 | +11,775 | Add 56.00% | 32,801 | $73.55 |
| Q2 2023 | +38,305 | Add 116.78% | 71,106 | $91.44 |
| Q3 2023 | +4,430 | Add 6.23% | 75,536 | $93.40 |
| Q4 2023 | -9,128 | Reduce 12.08% | 66,408 | $95.06 |
| Q1 2024 | +16,553 | Add 24.93% | 82,961 | $92.16 |
| Q2 2024 | +42,098 | Add 50.74% | 125,059 | $91.80 |
| Q3 2024 | +14,139 | Add 11.31% | 139,198 | $96.51 |
| Q4 2024 | +107,720 | Add 77.39% | 246,918 | $90.79 |
| Q1 2025 | +45,146 | Add 18.28% | 292,064 | $92.63 |
| Q2 2025 | +50,328 | Add 17.23% | 342,392 | $98.39 |
| Q3 2025 | -342,392 | Sold Out | 0 | $0.00 |
Joel Greenblatt's Amedisys Investment FAQs
Joel Greenblatt first purchased Amedisys, Inc. (AMED) in Q4 2014, acquiring 23,349 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Amedisys, Inc. (AMED) for 40 quarters since Q4 2014.
Joel Greenblatt's largest addition to Amedisys, Inc. (AMED) was in Q2 2015, adding 395,393 shares worth $15.71 M.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 0 shares of Amedisys, Inc. (AMED), valued at approximately $0.
As of the Q3 2025 filing, Amedisys, Inc. (AMED) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Amedisys, Inc. (AMED) was 395,393 shares, as reported at the end of Q2 2015.